Unique Ingredient Identifier NX76LV5T8J is listed as a ingredient substance
RN | 25212-88-8 |
NCIT | C83949 |
RXCUI | 1309718 |
MF | Polymer substance not supported |
UNII NX76LV5T8J METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A is commonly included in medications in the following forms.
Route | Dosage Form | Potency |
---|---|---|
ORAL | CAPSULE | 93.6 mg |
ORAL | CAPSULE, DELAYED ACTION | 82.513 mg |
ORAL | CAPSULE, DELAYED RELEASE | 79.22 mg |
ORAL | CAPSULE, DELAYED RELEASE | 56.76 mg |
ORAL | TABLET, CONTROLLED RELEASE | 22.74 mg |
ORAL | TABLET, DELAYED RELEASE | 40 mg |
ORAL | TABLET, EXTENDED RELEASE | 9.2 mg |
ORAL | CAPSULE, COATED PELLETS | 3.94 MG |
ORAL | CAPSULE, DELAYED ACTION, COATED, HARD GELATIN | 100.69 MG |
ORAL | CAPSULE, DELAYED RELEASE | 58.88 MG |
ORAL | CAPSULE, ENTERIC COATED PELLETS | 1500 MG |
ORAL | CAPSULE, HARD GELATIN | 2.2 MG |
ORAL | CAPSULE, SUSTAINED ACTION | 57.28 MG |
ORAL | CAPSULE, SUSTAINED ACTION, HARD GELATIN | 10.9 MG |
ORAL | GRANULE, FOR ORAL SUSPENSION | 38 MG |
ORAL | PELLET | 38 MG |
ORAL | SOLUTION | 3.68 MG |
ORAL | TABLET | 91 MG |
ORAL | TABLET, DELAYED ACTION, ENTERIC COATED | 140 MG |
ORAL | TABLET, ENTERIC COATED PARTICLES | 27.9 MG |
ORAL | TABLET, EXTENDED RELEASE | 133.34 MG |
ORAL | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE | 95 MG |
ORAL | TABLET, SUSTAINED ACTION | 7.2 MG |
ORAL | TABLET, SUSTAINED ACTION, COATED | 15 MG |